Quick answer
How should lyophilized melanotan II be stored? The MT-2 product page states: refrigerate at 2–8 °C, or at −20 °C for long-term storage, and protect from heat, moisture and light; the material is a lyophilized powder in a sealed clear glass research vial. This page explains the reasoning behind each of those three protections using the formulation literature, then turns it into a receiving routine, an aliquot plan and a log template. It does not state a shelf life for MT-2, because none of the cited sources does. For laboratory research use only; see the melanotan II research overview.
Storage guidance on a product page is short because it is meant to be followed, not debated. The reasons behind it are worth knowing because they tell you what to do in the situations the page does not cover: a vial left on the bench overnight, a freezer failure, a shipment that arrives warm, or a vial opened repeatedly over months. This article focuses on the dry, sealed or opened lyophilized vial; solution storage is a separate question covered in the stability-study article for this compound and in how long reconstituted peptides last. The material is supplied for laboratory research use only; not for human consumption.
What the product page specifies
The MT-2 product page lists a 10 mg size supplied as lyophilized powder, at least 98% purity by HPLC, formula C50H69N15O9 and the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. Storage is stated as refrigerate at 2–8 °C, with −20 °C for long-term storage, protected from heat, moisture and light, in a sealed clear glass research vial. Those three protections map to three mechanisms: temperature slows chemical reactions, low moisture limits mobility and hydrolysis in the solid, and light shields photosensitive residues. A clear vial transmits light, so shielding is something the user adds, for example by keeping the vial in its box or in an opaque secondary container.
A COA is marked as coming soon on the page. Before relying on any documentation, check the page again and read the COA page and how to read a COA to see what a lot document contains.
Why dry storage works, and its limits
Lyophilization removes water by sublimation, leaving a porous solid. A review of solid protein pharmaceuticals notes that proteins are often made into solid forms, most commonly by lyophilization, to achieve an acceptable shelf life, and that the process itself imposes freezing and drying stresses and that, even after successful lyophilization, proteins in the solid state may still have limited long-term storage stability (Wang, 2000). A separate paper offers practical advice on the rational design of stable lyophilized formulations (Carpenter et al., 1997); this page cites it only for that stated purpose.
The practical reading for a research vial: a sealed, dry vial held cold is the best-supported state, and each departure (warmth, humidity, light, repeated opening) removes some of that protection without necessarily causing visible change. A broad review of protein stability covers chemical and physical instability, stabilization in aqueous solution and in the dried state, and the interrelationship between chemical and physical instability (Manning et al., 2010). For the background process see what is lyophilization.
The three protections in detail
Temperature. Reaction rates fall as temperature falls, which is why the page gives a refrigerated range for ordinary storage and a freezer temperature for long-term holding. For a rule of thumb that is still a formula, the Arrhenius relation k = A·e−Ea/RT expresses that the rate constant rises steeply with temperature; the activation energy Ea differs for each degradation route and is not known for MT-2 from the sources cited here. Frost-free freezers cycle temperature and are a poor place for long-term stock; a manual-defrost unit holds temperature better.
Moisture. A cold vial opened in a warm room draws moisture from the air onto the powder as it warms. Let the sealed vial come to room temperature before opening, close it promptly, and consider a desiccant in the secondary container. Humidity is a sensible concern because, as the solid-state stability literature indicates, dried material can still have limited long-term stability (Wang, 2000); keeping water out is the conservative choice.
Light. Tryptophan, tyrosine and histidine residues are among the oxidation-prone ones listed in reviews of chemical instability, and oxidation can be catalyzed by metal ions and induced by light (Li et al., 1995). MT-2 contains tryptophan and histidine. Because the vial is clear glass, store it in the dark.
| Protection | Mechanism addressed | Practical step | Risk if ignored |
|---|---|---|---|
| Cold (2–8 °C or −20 °C) | Slows chemical reactions | Refrigerator for routine; manual-defrost freezer for long term | Faster loss of intact peptide |
| Dry | Limits hydrolysis and mobility | Warm to room temperature before opening; close promptly; desiccant | Moisture uptake; sticky or collapsed cake |
| Dark | Limits photo-oxidation | Keep in box or opaque container | Oxidized tryptophan or histidine |
| Sealed | Keeps out air and humidity | Do not leave open; re-seal after use | Oxidation and moisture |
A receiving and opening routine
- On arrival, inspect the vial and box, record the date and the lot number, and note whether the package felt warm. Place the vial in cold storage promptly.
- Record the appearance of the solid: intact cake or powder, white to off-white, dry. Any collapse, discoloration or stickiness is worth noting before use.
- Decide the plan for the whole vial before the first opening: how many experiments it will serve, and whether it will be reconstituted once and aliquoted, or kept dry and weighed. Dividing a stock into single-use aliquots avoids repeated warming and cooling.
- Warm to room temperature unopened, ideally in a desiccator or sealed bag, so condensation forms outside the container.
- Open in a clean, low-humidity area and close promptly. Do not leave the stopper off between steps.
- Return unused material to cold storage. If the whole vial is reconstituted, the remaining dry-storage question no longer applies and solution handling takes over; the steps are on how to reconstitute a lyophilized peptide.
Contamination and handling errors are as likely as chemistry to compromise a stock. Peptide recovery from different containers varies, which matters when peptide is transferred to working tubes (Goebel-Stengel et al., 2011). Keep transfers few and use validated tube types for dilute solutions.
Excursions: what to do when conditions slip
Real labs have excursions. A principled response is to document first and decide second. Record the duration and the temperature if known, whether the vial stayed sealed, and whether it was exposed to light. Then ask how sensitive the planned experiment is: for a qualitative assay a short, cool, sealed excursion may be immaterial, whereas for a quantitative potency comparison the same excursion could matter. The way to turn a worry into data is a small comparison: run the exposed vial and an unexposed reference on the same HPLC method and the same assay, as in forced-degradation practice in formulation science, where deliberate stress is used to see what degradation looks like and whether the method can detect it (Hawe et al., 2012).
No excursion rule can be taken from this page, since none of the cited sources provides one for MT-2; the point is the method. Your own stability data decide the rule. If the vial is the only lot for a critical study, it is reasonable to confirm identity and purity by an independent analytical lab before use.
| Excursion | Questions to ask | Low-cost check |
|---|---|---|
| Vial left at room temperature for a period | How long; sealed; lit? | Compare with a reference vial by HPLC |
| Freezer failure | Peak temperature reached; duration | Inspect appearance; HPLC if quantitative |
| Shipment arrived warm | Package condition; time in transit | Record; HPLC if critical |
| Vial opened repeatedly | Number of openings; humidity | Compare early and late use by HPLC |
| Exposed to bright light | Duration and light source | Look for new HPLC peaks |
A storage log template
A one-page log per vial is enough. Record: product and lot; date received; storage location and temperature; date and reason for every opening; who handled it; whether it was reconstituted, with date, solvent, volume and calculated concentration; the number and location of aliquots; and each use. The log answers the first question anyone asks when a result looks odd, which is what happened to the material. The calculation steps for stock preparation are in peptide reconstitution volume calculations and the calculator. For other research materials see the shop; for a quality-attribute view of the same vial see melanotan II purity testing.
Frequently asked questions
How should lyophilized melanotan II be stored?
Per the product page: refrigerate at 2–8 °C, or at −20 °C for long term, protected from heat, moisture and light.
Why protect it from moisture?
Solid-state proteins can still show limited long-term stability after lyophilization (Wang, 2000), so keeping the powder dry is the conservative choice.
Why does the vial need to warm up before opening?
To keep condensation off the powder; a cold vial opened in a warm room draws in moisture.
Is the vial light-protected?
The product page describes a clear glass vial, so keep it in a box or opaque container.
Which residues in MT-2 are light and oxidation sensitive?
Tryptophan and histidine are among the oxidation-prone residues in the chemical-instability literature (Li et al., 1995).
Is a freezer better than a refrigerator?
The page lists −20 °C for long-term storage. Use a manual-defrost unit if possible, because frost-free cycling varies temperature.
How long does the dry powder keep?
No cited source states a shelf life for MT-2; keep a log and use your own analytical checks if it matters.
What if the vial was left out?
Document the excursion, then compare with a reference vial by HPLC if the experiment is quantitative.
Should I split the vial?
Reconstituting once and freezing single-use aliquots limits repeated warming; test the approach in your system.
Does the COA cover storage history?
No. A COA describes testing of the lot; what happens after receipt belongs in your own log.
Responsible research use
Everything on this page is offered for laboratory research use only; it is background reading for qualified researchers, not guidance for any use outside a research setting, and nothing here is a claim about benefit in people or animals. Products from V8 Peptides are sold strictly as research materials: not a drug, food or cosmetic, and not for human or animal consumption. Published studies described here were run by their authors under their own approvals and protocols, and this page does not recommend repeating them.
Related reading: Melanotan II Structure: Lactam Ring and Synthesis, Melanotan II History: From alpha-MSH to Receptor Cloning, Melanotan II Mechanism: Receptor Binding and cAMP Assays.
References
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. doi:10.1016/S0378-5173(00)00423-3
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995;48(5):490-500. doi:10.1002/bit.260480511
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JHO, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. doi:10.1002/jps.22812
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR Jr. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009
- Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14(8):969-975. doi:10.1023/A:1012180707283
